TED Member States· European UniontenderOpen · 12 Nov 2026
Oral Cytostatic with the active substance Belzutifan
Fakultní nemocnice Ostrava
Tenders due 12 Nov 2026Tenders due12 Nov 2026
Estimated valueCZK 50,254,647
CPV category33652100
Published09 Oct 2026
Reference701999-2026
Notice summary
The subject of the public procurement is the ongoing and repeated supply of the medicinal product 'Oral Cytostatic with the active substance Belzutifan 40 mg in one coated tablet' (hereinafter referred to as 'MP'), in accordance with the ZD and its annexes. Individual deliveries will be realized based on partial orders from individual contracting authorities.
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.